ArticleJournal of inflammation research2026
A CRP-Albumin-Lymphocyte (CALLY) Index-Based Nomogram for Predicting Survival After Radical Surgery for Hypopharyngeal Squamous Cell Carcinoma.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypopharyngeal squamous cell carcinoma (HSCC) is an aggressive malignancy associated with a notably poor prognosis. This study assessed the prognostic significance of the CRP-albumin-lymphocyte (CALLY) index for disease-free survival (DFS) and overall survival (OS) in postoperative HSCC patients, and constructed nomograms integrating the CALLY index and other independent predictors to enhance clinical applicability of individualized survival prediction. Methods: This multicenter retrospective study of 278 postoperative HSCC patients had a 3:1 training/validation split. Multivariate Cox regression analyses were performed to identify clinicopathological variables independently associated with DFS and OS. A predictive nomogram incorporating these significant prognostic factors was subsequently developed. Following a series of validations, a risk stratification system was established based on the risk scores within the model. Results: Multivariate Cox regression analysis identified the CALLY index, eastern cooperative oncology group performance status (ECOG PS), stage, surgical margin, extranodal extension (ENE), and the age-adjusted Charlson comorbidity index (ACCI) as independent prognostic predictors of both DFS and OS. Using these predictors, two clinicopathological nomograms were developed-one to estimate DFS, and another for OS. Validations demonstrated robust discriminative ability, with area under the curve (AUC) values consistently exceeding those of the conventional AJCC staging system. Furthermore, a risk stratification system was established based on the integrated nomogram-derived total risk score, categorizing patients into different subgroups. Notably, subgroup analysis revealed that adjuvant radiotherapy was associated with statistically significant survival benefits exclusively among high- and medium-risk patients; no clinically meaningful improvement in DFS or OS was observed in the low-risk group. Conclusion: For postoperative HSCC patients, CALLY index serves as a significant independent prognostic factor for DFS and OS. The nomograms developed by CALLY index and other clinicopathological variables outperforms the staging system. Adjuvant radiotherapy warrants caution in low-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.